Report cover image

Europe Molecular Point Of Care Testing (Using NAAT) Market - Industry Trends and Forecast to 2028

Publisher Data Bridge Market Research
Published Sep 01, 2022
Length 214 Pages
SKU # DAABD17403919

Description

Europe Molecular Point Of Care Testing (Using NAAT) Market - Industry Trends and Forecast to 2028

Europe molecular point of care testing (using NAAT) market is projected to register a substantial CAGR of 10.8% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020, and the forecast period is 2021 to 2028.

Market Segmentation
Europe Molecular Point of Care Testing (using NAAT) Market, By Product (Instruments and Consumables & Reagents), Indication (Respiratory Infections Testing, Sexually Transmitted Infection (STI) Testing, Gastrointestinal Tract Infections Testing, and Others), End User (Laboratories, Hospitals, Clinics, Ambulatory Centers, Homecare, Assisted Living Facilities, and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country ( U.K., Germany, France, Spain, Italy, and Rest of Europe) – Industry Trends and Forecast to 2028

Some of the significant factors contributing to the growth of the Europe molecular point of care testing (using NAAT) market are:

• Increasing prevalence of chronic diseases
• Improving diagnosis-seeking rate
• Rising preference for homecare testing

Market Players

The key market players operating in the Europe molecular point of care testing (using NAAT) market are listed below:

• SD Biosensor, Inc.
• Abbott
• F.Hoffmann-La Roche Ltd.
• Danaher
• Thermo Fisher Scientific Inc
• binx Health, Inc.
• Lucira
• Meridian Bioscience
• Quantumdx Group Ltd.
• BD
• Biomérieux Sa
• Qiagen
• Quidel Corporation
• Bio-Rad Laboratories, Inc.
• Sekisui Diagnostic
• Randox Laboratories Ltd.
• GenMark Diagnostics
• Seegene Inc.
• Grifols S.A.
• Wondfo
• Oxford Nanopore Diagnostic
• PerkinElmer Inc.


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

214 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Europe Molecular Point Of Care Testing (Using Naat) Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Primary Interviews With Key Opinion Leaders
2.7 Multivariate Modelling
2.8 Distribution Channel Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Market End User Coverage Grid
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Porters Five Forces
4.2 Pestel Analysis
4.3 Annual Test Volume: For All Countries
4.3.1 Cepheid
4.3.2 Thermo Fisher Scientific Inc.
4.3.3 Hologic, Inc.
4.3.4 Bd
4.3.5 F. Hoffmann-la Roche Ltd
4.4 Number Of Poct Instruments Installed In Each Country
4.5 Distributors
4.5.1 North America
4.5.2 Europe
4.5.3 South Asia
4.5.4 South East Asia
4.5.5 Middle East
4.5.6 Africa
5 Regulatory Framework
6 Market Overview
6.1 Drivers
6.1.1 Increasing Prevalence Of Chronic Diseases
6.1.2 Improving Diagnosis Seeking Rate
6.1.3 Rising Technological Advancements
6.1.4 Rising Geriatric Population Across Globe
6.1.5 Rising Preference For Homecare Testing
6.2 Restraints
6.2.1 Product Recalls
6.2.2 High Costs Of Products
6.2.3 Non-availability Of Relevant And Appropriate Kits
6.3 Opportunities
6.3.1 Strategic Initiatives Taken By Market Players
6.3.2 Rising Healthcare Expenditure
6.3.3 Pandemic Outbreak Of Covid-19
6.3.4 Growing Demand For Better Quality Healthcare And Early Diagnosis
6.4 Challenges
6.4.1 Lack Of Alignment With Test Results Obtained From Laboratories
6.4.2 Lack Of Accessibility
7 Impact Of Covid-19 On The Europe Molecular Point Of Care Testing (Using Naat) Market
7.1 Impact On Price
7.2 Impact On Demand
7.3 Impact On Supply Chain
7.4 Key Initiatives By Market Players During The Covid 19
7.5 Conclusion:
8 Europe Molecular Point Of Care Testing (Using Naat) Market, By Product
8.1 Overview
8.2 Consumables & Reagents
8.3 Instruments
8.3.1 Mobile Platform (Small & Portable)
8.3.2 Facility-based Platforms (Large Poct Platform)
9 Europe Molecular Point Of Care Testing (Using Naat) Market, By Indication
9.1 Overview
9.2 Respiratory Infections Testing
9.2.1 Covid-19
9.2.2 Flu B
9.2.3 Flu A
9.2.4 Rsv
9.2.5 Tuberculosis
9.2.6 Pneumonia (Pneumococcal Pneumonia)
9.2.7 Others
9.3 Sexually Transmitted Infection (Sti) Testing
9.3.1 Tv
9.3.2 Ct
9.3.3 Ng
9.3.4 Hpv
9.3.5 Hsv
9.3.6 Mg
9.3.7 Uu
9.3.8 Mh
9.3.9 Others
9.4 Gastrointestinal Tract Infections Testing
9.4.1 Group B Streptococcus
9.4.2 Shiga Toxin
9.4.3 H. Pylori
9.5 Others
10 Europe Molecular Point Of Care Testing (Using Naat) Market, By End User
10.1 Overview
10.2 Laboratories
10.2.1 Polymerase Chain Reaction
10.2.2 Isothermal Amplification
10.3 Hospital
10.3.1 Polymerase Chain Reaction
10.3.2 Isothermal Amplification
10.4 Clinics
10.4.1 Polymerase Chain Reaction
10.4.2 Isothermal Amplification
10.5 Ambulatory Center
10.5.1 Polymerase Chain Reaction
10.5.2 Isothermal Amplification
10.6 Homecare
10.6.1 Polymerase Chain Reaction
10.6.2 Isothermal Amplification
10.7 Assisted Living Facilities
10.7.1 Polymerase Chain Reaction
10.7.2 Isothermal Amplification
10.8 Others
11 Europe Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing
11.1 Overview
11.2 Prescription-based Testing
11.3 Otc Testing
12 Europe Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel
12.1 Overview
12.2 Hospital Pharmacy
12.3 Retail Pharmacy
12.4 Online Pharmacy
13 Europe Molecular Point Of Care Testing (Using Naat) Market, By Region
13.1 Europe
13.1.1 U.K.
13.1.2 Germany
13.1.3 Italy
13.1.4 France
13.1.5 Spain
13.1.6 Rest Of Europe
14 Europe Molecular Point Of Care Testing (Using Naat) Market: Company Landscape
14.1 Company Share Analysis: Europe
15 Swot Analysis
16 Company Profile
16.1 Danaher
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Company Share Analysis
16.1.4 Product Portfolio
16.1.5 Recent Developments
16.2 Thermo Fisher Scientific Inc.
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Company Share Analysis
16.2.4 Product Portfolio
16.2.5 Recent Developments
16.3 Bd
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Company Share Analysis
16.3.4 Product Portfolio
16.3.5 Recent Developments
16.4 F.Hoffmann-la-roche Ltd.
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Company Share Analysis
16.4.4 Product Portfolio
16.4.5 Recent Developments
16.5 Abbott
16.5.1 Company Snapshot
16.5.2 Revenue Analysis
16.5.3 Product Portfolio
16.5.4 Recent Developments
16.6 Binx Health, Inc.
16.6.1 Company Snapshot
16.6.2 Product Portfolio
16.6.3 Recent Development
16.7 Biomerieux Sa
16.7.1 Company Snapshot
16.7.2 Revenue Analysis
16.7.3 Product Portfolio
16.7.4 Recent Development
16.8 Co-diagnostics, Inc.
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Product Portfolio
16.8.4 Recent Developments
16.9 Genmark Diagnostics, Inc
16.9.1 Company Snapshot
16.9.2 Revenue Analysis
16.9.3 Product Portfolio
16.9.4 Recent Development
16.10 Grifols, S.A.
16.10.1 Company Snapshot
16.10.2 Revenue Analysis
16.10.3 Product Portfolio
16.10.4 Recent Development
16.11 Lucira Health Inc.
16.11.1 Company Snapshot
16.11.2 Product Portfolio
16.11.3 Recent Developments
16.12 Meridian Bioscience
16.12.1 Company Snapshot
16.12.2 Revenue Analysis
16.12.3 Product Portfolio
16.12.4 Recent Developments
16.13 Quantumdx Group Ltd.
16.13.1 Company Snapshot
16.13.2 Product Portfolio
16.13.3 Recent Developments
16.14 Quidel Corporation
16.14.1 Company Snapshot
16.14.2 Revenue Analysis
16.14.3 Product Portfolio
16.14.4 Recent Development
16.15 Sd Biosensor, Inc.
16.15.1 Company Snapshot
16.15.2 Product Portfolio
16.15.3 Recent Development
16.16 Sekisui Diagnostics (A Subsidiary Of Sekisui Medical)
16.16.1 Company Snapshot
16.16.2 Product Portfolio
16.16.3 Recent Development
16.17 Sysmex (A Subsidiary Of Sysmex Corporation
16.17.1 Company Snapshot
16.17.2 Revenue Analysis
16.17.3 Product Portfolio
16.17.4 Recent Development
16.18 Wondfo
16.18.1 Company Snapshot
16.18.2 Product Portfolio
16.18.3 Recent Development
17 Questionnaire
18 Related Reports 214
List Of Tables
Table 1 Cepheid: Annual Test Volume, For All Countries, 2020 (Units)
Table 2 Thermo Fisher Scientific Inc. : Annual Test Volume, For All Countries, 2020 (Units)
Table 3 Hologic, Inc. : Annual Test Volume, For All Countries, 2020 (Units)
Table 4 Bd : Annual Test Volume, For All Countries, 2020 (Units)
Table 5 F. Hoffmann-la Roche Ltd : Annual Test Volume, For All Countries, 2020 (Units)
Table 6 Number Of Poct Instruments Installed In Each Country, 2020 (Units)
Table 7 Distributors Across North America
Table 8 Distributors Across Europe
Table 9 Distributors Across South Asia
Table 10 Distributors Across South East Asia
Table 11 Distributors Across Middle East
Table 12 Distributors Across Africa
Table 13 Europe Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 14 Europe Consumables & Reagents In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 15 Europe Instruments In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 16 Europe Instruments In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 17 Europe Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 18 Europe Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 19 Europe Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 20 Europe Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 21 Europe Sexually Transmitted In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 22 Europe Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 23 Europe Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 24 Europe Others In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 25 Europe Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 26 Europe Laborotories In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 27 Europe Laborotories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 28 Europe Hospital In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 29 Europe Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 30 Europe Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 31 Europe Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 32 Europe Ambulatory Center In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 33 Europe Ambulatory Center In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 34 Europe Home Care In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 35 Europe Home Care In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 36 Europe Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 37 Europe Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 38 Europe Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 39 Europe Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 40 Europe Prescription-based Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region 2019-2028 (Usd Million)
Table 41 Europe Otc Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 42 Europe Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 43 Europe Hospital Pharmacy In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 44 Europe Retail Pharmacy In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 45 Europe Online Pharmacy In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 46 Europe Molecular Point Of Care Testing (Using Naat) Market, By Country, 2019-2028 (Usd Million)
Table 47 Europe Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 48 Europe Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 49 Europe Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 50 Europe Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 51 Europe Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 52 Europe Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 53 Europe Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 54 Europe Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 55 Europe Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 56 Europe Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 57 Europe Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 58 Europe Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 59 Europe Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 60 Europe Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 61 Canada Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 62 U.K. Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 63 U.K. Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 64 U.K. Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 65 U.K. Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 66 U.K. Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 67 U.K. Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 68 U.K. Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 69 U.K. Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 70 U.K. Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 71 U.K. Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 72 U.K. Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 73 U.K. Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 74 U.K. Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 75 U.K. Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 76 Canada Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 77 Germany Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 78 Germany Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 79 Germany Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 80 Germany Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 81 Germany Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 82 Germany Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 83 Germany Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 84 Germany Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 85 Germany Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 86 Germany Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 87 Germany Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 88 Germany Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 89 Germany Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 90 Germany Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 91 Canada Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 92 Italy Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 93 Italy Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 94 Italy Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 95 Italy Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 96 Italy Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 97 Italy Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 98 Italy Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 99 Italy Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 100 Italy Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 101 Italy Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 102 Italy Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 103 Italy Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 104 Italy Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 105 Italy Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 106 Italy Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 107 France Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 108 France Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 109 France Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 110 France Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 111 France Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 112 France Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 113 France Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 114 France Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 115 France Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 116 France Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 117 France Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 118 France Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 119 France Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 120 France Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 121 France Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 122 Spain Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 123 Spain Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 124 Spain Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 125 Spain Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 126 Spain Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 127 Spain Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 128 Spain Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 129 Spain Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 130 Spain Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 131 Spain Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 132 Spain Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 133 Spain Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 134 Spain Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 135 Spain Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 136 Spain Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 137 Rest Of Europe Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million) 156
List Of Figures
Figure 1 Europe Molecular Point Of Care Testing (Using Naat) Market: Segmentation
Figure 2 Europe Molecular Point Of Care Testing (Using Naat) Market: Data Triangulation
Figure 3 Europe Molecular Point Of Care Testing (Using Naat) Market: Droc Analysis
Figure 4 Europe Molecular Point Of Care Testing (Using Naat) Market: Europe Vs Regional Market Analysis
Figure 5 Europe Molecular Point Of Care Testing (Using Naat) Market: Company Research Analysis
Figure 6 Europe Molecular Point Of Care Testing (Using Naat) Market: Interview Demographics
Figure 7 Europe Molecular Point Of Care Testing (Using Naat) Market: Multivariate Modelling
Figure 8 Europe Molecular Point Of Care Testing (Using Naat) Market: Dbmr Market Position Grid
Figure 9 Europe Molecular Point Of Care Testing (Using Naat) Market: Vendor Share Analysis
Figure 10 Europe Molecular Point Of Care Testing (Using Naat) Market: End User Overage Grid
Figure 11 Europe Molecular Point Of Care Testing (Using Naat) Market: Segmentation
Figure 12 North America Is Expected To Dominate The Europe Molecular Point Of Care Testing (Using Naat) Market And Is Expected To Grow With The Highest Cagr In The Forecast Period
Figure 13 Increasing Prevalence Of Chronic Disease And Improving Diagnosis-seeking Rate Are Expected To Drive The Europe Molecular Point Of Care Testing (Using Naat) Market In The Forecast Period
Figure 14 Consumables And Reagents Segment Is Expected To Account For The Largest Share Of The Europe Molecular Point Of Care Testing (Using Naat) Market In 2021 & 2028
Figure 15 Asia-pacific Is The Fastest Growing Market For The Molecular Point Of Care Testing (Using Naat) Manufacturers In The Forecast Period
Figure 16 Drivers, Restraints, Opportunities, And Challenges Of Europe Molecular Point Of Care Testing (Using Naat) Market
Figure 17 Medical Device Spending Vs National Health Expenditures, 2016
Figure 18 Europe Molecular Point Of Care Testing (Using Naat) Market: By Product, 2020
Figure 19 Europe Molecular Point Of Care Testing (Using Naat) Market: By Product, 2021-2028 (Usd Million)
Figure 20 Europe Molecular Point Of Care Testing (Using Naat) Market: By Product, Cagr (2021-2028)
Figure 21 Europe Molecular Point Of Care Testing (Using Naat) Market: By Product, Lifeline Curve
Figure 22 Europe Molecular Point Of Care Testing (Using Naat) Market: By Indication, 2020
Figure 23 Europe Molecular Point Of Care Testing (Using Naat) Market: By Indication, 2021-2028 (Usd Million)
Figure 24 Europe Molecular Point Of Care Testing (Using Naat) Market: By Indication, Cagr (2021-2028)
Figure 25 Europe Molecular Point Of Care Testing (Using Naat) Market: By Indication, Lifeline Curve
Figure 26 Europe Molecular Point Of Care Testing (Using Naat) Market: By End User, 2020
Figure 27 Europe Molecular Point Of Care Testing (Using Naat) Market: By End User, 2021-2028 (Usd Million)
Figure 28 Europe Molecular Point Of Care Testing (Using Naat) Market: By End User, Cagr (2021-2028)
Figure 29 Europe Molecular Point Of Care Testing (Using Naat) Market: By End User, Lifeline Curve
Figure 30 Europe Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, 2020
Figure 31 Europe Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, 2021-2028 (Usd Million)
Figure 32 Europe Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, Cagr (2021-2028)
Figure 33 Europe Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, Lifeline Curve
Figure 34 Europe Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, 2020
Figure 35 Europe Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, 2021-2028 (Usd Million)
Figure 36 Europe Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, Cagr (2021-2028)
Figure 37 Europe Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, Lifeline Curve
Figure 38 Europe Molecular Point Of Care Testing (Using Naat) Market: Snapshot (2020)
Figure 39 Europe Molecular Point Of Care Testing (Using Naat) Market: By Country (2020)
Figure 40 Europe Molecular Point Of Care Testing (Using Naat) Market: By Country (2021 & 2028)
Figure 41 Europe Molecular Point Of Care Testing (Using Naat) Market: By Country (2020 & 2028)
Figure 42 Europe Molecular Point Of Care Testing (Using Naat) Market: By Product (2021-2028)
Figure 43 Europe Molecular Point Of Care Testing (Using Naat) Market: Company Share 2020 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us